Who Owns Dermata Therapeutics, Inc. Warrant (DRMAW)?Hedge Fund & Institutional Holders

$0.02+0.00 (+1.09%)HealthcareNASDAQ

Institutional Holders

2

as of Q4 2025

Total Institutional Value

$0

% of Float Held

QoQ Change in Holders

+0 / -1

Price History

$0.01$0.01$0.02$0.03$0.04Jun 23Jan 25Mar 26

DRMAW — Biggest New Institutional Buyers This Quarter

FundActionShares AddedValue Added
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased+2K+$-225K

DRMAW — Institutions Reducing or Closing Positions

FundActionShares SoldValue Sold
UBS Group AGClosed Position-1K-$22K

Top Institutional Holders(Q4 2025)

#FundSharesValue% of PortfolioType
1SUSQUEHANNA INTERNATIONAL GROUP, LLP12,671$00.00%Share
2BOOTHBAY FUND MANAGEMENT, LLC12,000$00.00%Share

DRMAW Institutional Ownership History

QuarterHoldersTotal ValueChange
Q4 20252$0-1
Q3 20253$60.5M-3
Q2 20256$7.5M+3
Q1 20253$13.2M-3
Q4 20246$16.4M+2
Q3 20244$19.7B-1
Q2 20245$28.8B-1
Q1 20246$5.1B

Similar Stocks by Institutional Ownership

As of Q4 2025, 2 institutional investors hold DRMAW (Dermata Therapeutics, Inc. Warrant). The largest holder is SUSQUEHANNA INTERNATIONAL GROUP, LLP with $0 in shares. This quarter, 0 institutions opened new positions and 1 closed their positions.

Frequently Asked Questions

How many hedge funds own DRMAW?

As of Q4 2025, 2 institutional investors report holding DRMAW (Dermata Therapeutics, Inc. Warrant) in their 13F filings.

Who is the largest institutional holder of DRMAW?

The largest institutional holder of DRMAW is SUSQUEHANNA INTERNATIONAL GROUP, LLP with $0 in shares.

Is institutional ownership of DRMAW increasing or decreasing?

This quarter, 0 institutions opened new positions in DRMAW and 1 closed their positions.